Tolga Tanguler, EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 2,391 shares at $229.06 ($552K) on 2024-06-25, disclosed to the SEC on 2024-06-26.
Open-market sale of $552k ALNY by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $221.71 | 59 | $13K | 2.4% |
| 2 | $224.17 | 13 | $3K | 0.5% |
| 3 | $225.55 | 18 | $4K | 0.7% |
| 4 | $226.82 | 34 | $8K | 1.4% |
| 5 | $228.30 | 129 | $29K | 5.3% |
| 6 | $229.06 | 266 |
| $61K |
| 11.0% |
| 7 | $229.06 | 266 | $61K | 11.0% |
| 8 | $229.93 | 304 | $70K | 12.7% |
| 9 | $229.93 | 304 | $70K | 12.7% |
| 10 | $231.59 | 99 | $23K | 4.2% |
| 11 | $232.54 | 216 | $50K | 9.1% |
| 12 | $232.54 | 216 | $50K | 9.1% |
| 13 | $233.53 | 115 | $27K | 4.9% |
| 14 | $234.66 | 185 | $43K | 7.9% |
| 15 | $235.19 | 167 | $39K | 7.1% |
| Total | $230.78 avg | 2,391 | $552K | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $607K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |
| ALNY | SELL | 2025-10-03 | $1.1M | — | Filing → |